Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ijc.32894
PubMed Identifier: 32012253
Publication URI: http://europepmc.org/abstract/MED/32012253
Type: Journal Article/Review
Volume: 147
Parent Publication: International journal of cancer
Issue: 5
ISSN: 0020-7136